CMT and Mental Health: What the Data Is Telling Us This May
May is Mental Health Awareness Month, and this year, HNF is using it as a moment to look honestly at something the CMT community has been living with for a long time: the emotional weight of this disease is real, it is measurable, and it deserves the same attention as the physical symptoms.
GRIN, the Global Registry and Inherited Neuropathies for CMT, now holds data from 2,864 participants. What that data shows about mental health is striking.
The emotional toll is not separate from the disease. It is part of it.
Among GRIN participants who completed the Mental Health Survey, 81% report experiencing pain, with most rating it a 4 or higher on a 10-point scale. That persistent, daily pain does not exist in a vacuum. It shapes how people feel about themselves, their relationships, and their future.
Anxiety and fear are reported as quality-of-life symptoms by 44% of participants. Depression affects 34%. More than a third report awkward social interactions as a meaningful burden. These are not side effects of CMT. They are part of the CMT experience.
The isolation data is some of the most telling in the entire dataset. When asked about feelings of social disconnection, more than half of mental health survey respondents say they sometimes, usually, or always feel isolated even when other people are around. Nearly two-thirds say they feel left out at least some of the time. One in four disagrees that their life is satisfying.
This is not data about weakness. It is data about what it actually means to navigate a progressive, often invisible disease in a world that does not always understand it.
The physical picture behind the mental health burden
To understand why so many people with CMT are carrying emotional weight, you have to look at what the physical data shows.
Three out of four participants report falls or near-falls. 87% experience ankle and leg weakness across all CMT subtypes. Fatigue affects nearly 6 in 10 people. Sleeping issues affect more than a third. When you live with that combination of symptoms every day, the emotional consequences are not surprising. They are predictable. And they are documentable.
That documentation is exactly what GRIN makes possible.
Why your participation in GRIN matters right now
Data like this does not advocate for itself. Researchers, drug developers, and regulators need a clear, detailed picture of what the CMT community experiences, including the mental health piece, before they invest in solutions. GRIN is that picture.
Every survey response you submit adds depth and credibility to the dataset. The mental health data in particular is still growing, and it is among the most underrepresented areas in CMT research. When you answer those questions honestly, you are making the case that CMT is not just a peripheral nerve disease. It is a whole-person condition that demands whole-person solutions.
If you are already enrolled, log in and check for additional surveys or update any responses that no longer reflect where you are. CMT changes over time, and your updated experience matters.
If you are not yet enrolled, this month is a meaningful time to start. GRIN is free and open to anyone with CMT, a suspected diagnosis, or a family member living with the disease.
Visit JoinGRIN.org to enroll or update your surveys today.
0 Comments